About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
European Neuropsychopharmacology
›
Top Articles
European Neuropsychopharmacology
Psychiatry
,
Neurology
,
Psychology
,
Pharmacology
,
Psychobiology
,
Clinical Neurology
1.2
(top 17%)
Impact Factor
1.3
(top 17%)
extended IF
117
(top 3%)
H-Index
4K
authors
10.8K
papers
105.7K
citations
5.5K
citing journals
51K
citing authors
Most Cited Articles of European Neuropsychopharmacology
Title
Year
Citations
The size and burden of mental disorders and other disorders of the brain in Europe 2010
2011
2.2K
Exploring the brain network: a review on resting-state fMRI functional connectivity
2010
1.9K
Cost of disorders of the brain in Europe 2010
2011
987
Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies
2005
935
Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism
2002
444
Size of burden of schizophrenia and psychotic disorders
2005
406
Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial
2003
364
Inflammation and clinical response to treatment in depression: A meta-analysis
2015
360
Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses
2012
360
Prevalence and incidence of Parkinson's disease in Europe
2005
355
Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action
2010
338
The impact of stress on addiction
2003
304
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)
1997
295
Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence
2011
293
Treatment resistant depression: methodological overview and operational criteria
1999
272
Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)
1997
271
The hippocampal-prefrontal pathway: the weak link in psychiatric disorders?
2013
267
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD
2009
267
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy
1998
262
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy
2012
238
A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence
2013
231
Size and burden of social phobia in Europe
2005
227
Prevalence and burden of bipolar disorders in European countries
2005
226
Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
2006
226
Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis
2001
224
previous
2013
2014
2015
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.